Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

Por Halpern, Rachel, Agarwal, Sonalee, Dembek, Carole, Borton, Leigh, Lopez-Bresnahan, Maria
Publicado em 2011

Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study

Por Stephenson Judith J, Kern David M, Agarwal Sonalee S, Zeidman Ruth, Rajagopalan Krithika, Kamat Siddhesh A, Foley John
Publicado em 2012-12-01

Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study

Por Stephenson, Judith J, Kern, David M, Agarwal, Sonalee S, Zeidman, Ruth, Rajagopalan, Krithika, Kamat, Siddhesh A, Foley, John
Publicado em 2012

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

Por Foley, John F, Nair, Kavita V, Vollmer, Timothy, Stephenson, Judith J, Niecko, Timothy, Agarwal, Sonalee S, Watson, Crystal
Publicado no Patient Prefer Adherence (2017)